AAAAAA

   
Results: 1-25 | 26-39 |
Results: 26-39/39
Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation - A community hospital's experience
Authors: Brotzman, GL Kretzchmar, S Ferguson, D Gottlieb, M Stowe, C
Citation: Gl. Brotzman et al., Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation - A community hospital's experience, ARCH FAM M, 8(1), 1999, pp. 52-55
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor
Authors: Prasad, JVNV Boyer, FE Domagala, JM Ellsworth, EL Gajda, C Hamilton, HW Hagen, SE Markoski, LJ Steinbaugh, BA Tait, BD Humblet, C Lunney, EA Pavlovsky, A Rubin, JR Ferguson, D Graham, N Holler, T Hupe, D Nouhan, C Tummino, PJ Urumov, A Zeikus, E Zeikus, G Gracheck, SJ Saunders, JM VanderRoest, S Brodfuehrer, J Iyer, K Sinz, M Gulnik, SV Erickson, JW
Citation: Jvnv. Prasad et al., Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor, BIO MED CH, 7(12), 1999, pp. 2775-2800
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety.
Authors: Prasad, JVNV Markoski, LJ Boyer, FE Domagala, JM Ellsworth, EL Gajda, C Hagen, SE Tait, BD Lunney, EA Tummino, PJ Ferguson, D Holler, T Hupe, D Nouhan, C Gracheck, SJ VanderRoest, S Saunders, J Iyer, K Sinz, M
Citation: Jvnv. Prasad et al., Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety., BIOORG MED, 9(15), 1999, pp. 2217-2222
4-Hydroxy-5,6-dihydro-2H-pyran-2-ones. 3. Bicyclic and heteroaromatic ringsystems as 3-position scaffolds to bind to S-1 ' and S-2 ' of the HIV-1 protease enzyme.
Authors: Ellsworth, EL Domagala, J Prasad, JVNV Hagen, S Ferguson, D Holler, T Hupe, D Graham, N Nouhan, C Tummino, PJ Zeikus, G Lunney, EA
Citation: El. Ellsworth et al., 4-Hydroxy-5,6-dihydro-2H-pyran-2-ones. 3. Bicyclic and heteroaromatic ringsystems as 3-position scaffolds to bind to S-1 ' and S-2 ' of the HIV-1 protease enzyme., BIOORG MED, 9(14), 1999, pp. 2019-2024
Nonpeptidic HIV protease inhibitors: 6-alkyl-5, 6-dihydroyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl, 5-methylphenyl trio) moiety: Antiviral activities and pharmacokinetic properties
Authors: Prasad, JVNV Boyer, FE Domagala, JM Ellsworth, EL Gajda, C Hagen, SE Markoski, LJ Tait, BD Lunney, EA Tummino, PJ Ferguson, D Holler, T Hupe, D Nouhan, C Gracheck, SJ VanderRoest, S Saunders, J Iyer, K Sinz, M Brodfuehrer, J
Citation: Jvnv. Prasad et al., Nonpeptidic HIV protease inhibitors: 6-alkyl-5, 6-dihydroyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl, 5-methylphenyl trio) moiety: Antiviral activities and pharmacokinetic properties, BIOORG MED, 9(11), 1999, pp. 1481-1486
A comparison of hip guidance with reciprocating gait orthoses in children with spinal paraplegia: Results of a ten-year prospective study
Authors: Robb, JE Gordon, L Ferguson, D Dunhill, Z Elton, RA Minns, RA
Citation: Je. Robb et al., A comparison of hip guidance with reciprocating gait orthoses in children with spinal paraplegia: Results of a ten-year prospective study, EUR J PED S, 9, 1999, pp. 15-18
Using ceramic membranes to recycle two nonionic alkaline metal-cleaning solutions
Authors: Chen, ASC Stencel, N Ferguson, D
Citation: Asc. Chen et al., Using ceramic membranes to recycle two nonionic alkaline metal-cleaning solutions, J MEMBR SCI, 162(1-2), 1999, pp. 219-234
Preliminary clinical experience of a contracture correction device
Authors: Charlton, P Ferguson, D Peacock, C Stallard, J
Citation: P. Charlton et al., Preliminary clinical experience of a contracture correction device, PROS ORTHOT, 23(2), 1999, pp. 163-168
'Eight and a Half Conditions for the Existence of Restricted Code'
Authors: Ferguson, D
Citation: D. Ferguson, 'Eight and a Half Conditions for the Existence of Restricted Code', BOUND TWO, 26(1), 1999, pp. 113-114
Nonhomologous end-joining proteins are required for V(D)J recombination, normal growth, and neurogenesis
Authors: Sekiguchi, JM Gao, Y Gu, Y Frank, K Sun, Y Chaudhuri, J Zhu, C Cheng, HL Manis, J Ferguson, D Davidson, L Greenberg, ME Alt, FW
Citation: Jm. Sekiguchi et al., Nonhomologous end-joining proteins are required for V(D)J recombination, normal growth, and neurogenesis, COLD S HARB, 64, 1999, pp. 169-181
Ethnic dental analysis of shovel and Carabelli's traits in a Chinese population
Authors: Hsu, JW Tsai, PL Hsiao, TH Chang, HP Lin, LM Liu, KM Yu, HS Ferguson, D
Citation: Jw. Hsu et al., Ethnic dental analysis of shovel and Carabelli's traits in a Chinese population, AUST DENT J, 44(1), 1999, pp. 40-45
The 2C T-cell transgenic mouse: An in vivo model of allospecific cytotoxicT-cell activation and homing
Authors: Stegall, MD Elices, M Shepard, G Gup, C Ninova, D Ferguson, D Gill, RG
Citation: Md. Stegall et al., The 2C T-cell transgenic mouse: An in vivo model of allospecific cytotoxicT-cell activation and homing, TRANSPLAN P, 31(1-2), 1999, pp. 779-779
The 'Peony Pavilion': Chinese classical opera Kunqu - Inedit W-260060 (Joel Beaudemont, Pierre Bois)
Authors: Ferguson, D
Citation: D. Ferguson, The 'Peony Pavilion': Chinese classical opera Kunqu - Inedit W-260060 (Joel Beaudemont, Pierre Bois), YEAR TRAD M, 30, 1998, pp. 198-199
Assessment of intratumoral vascularization (angiogenesis) in breast cancerprognosis
Authors: Heimann, R Ferguson, D Gray, S Hellman, S
Citation: R. Heimann et al., Assessment of intratumoral vascularization (angiogenesis) in breast cancerprognosis, BREAST CANC, 52(1-3), 1998, pp. 147-158
Risultati: 1-25 | 26-39 |